[go: up one dir, main page]

ATE213158T1 - Pharmazeutische emulsion - Google Patents

Pharmazeutische emulsion

Info

Publication number
ATE213158T1
ATE213158T1 AT95900965T AT95900965T ATE213158T1 AT E213158 T1 ATE213158 T1 AT E213158T1 AT 95900965 T AT95900965 T AT 95900965T AT 95900965 T AT95900965 T AT 95900965T AT E213158 T1 ATE213158 T1 AT E213158T1
Authority
AT
Austria
Prior art keywords
pct
pharmaceutical emulsion
date
sec
pub
Prior art date
Application number
AT95900965T
Other languages
English (en)
Inventor
Kjell Hjalmar Andersson
Eva Kristina Byroed
Anna-Carin Hansson
Margareta Nordlander
Rolf Christer Westerlund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE213158T1 publication Critical patent/ATE213158T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT95900965T 1993-11-12 1994-11-03 Pharmazeutische emulsion ATE213158T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303744A SE9303744D0 (sv) 1993-11-12 1993-11-12 Pharmaceutical emulsion
PCT/SE1994/001032 WO1995013066A1 (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion

Publications (1)

Publication Number Publication Date
ATE213158T1 true ATE213158T1 (de) 2002-02-15

Family

ID=20391731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95900965T ATE213158T1 (de) 1993-11-12 1994-11-03 Pharmazeutische emulsion

Country Status (31)

Country Link
US (1) US5739152A (de)
EP (1) EP0727997B1 (de)
JP (1) JP3759951B2 (de)
KR (1) KR100345627B1 (de)
CN (1) CN1072934C (de)
AT (1) ATE213158T1 (de)
AU (1) AU678650B2 (de)
CA (1) CA2176360C (de)
CZ (1) CZ290772B6 (de)
DE (1) DE69429871T2 (de)
DK (1) DK0727997T3 (de)
EE (1) EE03223B1 (de)
EG (1) EG20764A (de)
ES (1) ES2172572T3 (de)
FI (1) FI116999B (de)
HK (1) HK1013261A1 (de)
HU (1) HU223142B1 (de)
IL (1) IL111345A (de)
IS (1) IS2036B (de)
MY (1) MY121201A (de)
NO (1) NO314877B1 (de)
NZ (1) NZ276197A (de)
PL (1) PL181462B1 (de)
PT (1) PT727997E (de)
RU (1) RU2144358C1 (de)
SA (1) SA94150314B1 (de)
SE (1) SE9303744D0 (de)
SK (1) SK283271B6 (de)
UA (1) UA40633C2 (de)
WO (1) WO1995013066A1 (de)
ZA (1) ZA948180B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
EP1079808B1 (de) * 1998-05-29 2004-02-11 Skyepharma Canada Inc. Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
DE10036871A1 (de) 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
EP1401396A4 (de) 2001-06-15 2009-08-05 Cornerstone Pharmaceuticals Pharmazeutische und diagnostische zusammensetzungen mit nanopartikeln für die behandlung von zielgeweben und zellen
BRPI0409133B8 (pt) 2003-04-08 2021-05-25 Progenics Pharm Inc preparações farmacêuticas estavéis compreendendo metilnaltrexona
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
EP2139890B1 (de) * 2007-03-29 2014-06-25 Wyeth LLC Peripherer opioid-rezeptor antagonisten und verwendungen davon
BRPI0809579B8 (pt) 2007-03-29 2021-05-25 Progenics Pharm Inc formas cristalinas e seus usos
CA2682125C (en) 2007-03-29 2015-06-16 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
KR101581480B1 (ko) 2008-02-06 2015-12-30 프로제닉스 파머슈티컬스, 인코포레이티드 (r),(r)-2,2'-비스-메틸날트렉손의 제조법 및 용도
JP2011529879A (ja) * 2008-08-01 2011-12-15 ザ メディシンズ カンパニー 医薬組成物およびこれを安定化させる方法
EA021336B1 (ru) * 2008-08-01 2015-05-29 Дзе Медсинз Компани Фармацевтические композиции и способы их получения при низкой концентрации примесей
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
WO2010107081A1 (ja) * 2009-03-19 2010-09-23 第一三共株式会社 包装により安定保存された固形製剤
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
US8658676B2 (en) * 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
DK2627173T4 (en) * 2010-10-12 2018-10-22 Chiesi Farm Spa CLEVIDIPINE EMULSUM FORMULATIONS CONTAINING ANTIMICROBIANTS
CN102531998A (zh) * 2010-12-09 2012-07-04 天津药物研究院 α型多晶型丁酸氯维地平结晶、其制备方法、用途和药物组合物
CN102525918A (zh) * 2010-12-30 2012-07-04 天津药物研究院 一种丁酸氯维地平的脂肪乳注射液及其制备工艺
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
AU2012236332A1 (en) 2011-04-01 2013-10-31 Chiesi Farmaceutici S.P.A. Short -acting dihydropyridines (clevidipine) for use in reducing stroke damage
CN110075310A (zh) 2011-12-20 2019-08-02 维奥姆治疗有限公司 用于治疗真菌感染的局部油组合物
TR201807636T4 (tr) 2012-10-26 2018-06-21 Chiesi Farm Spa Kalp yetmezliğinde kan basıncının kontrol edilmesi ve dispnenin azaltılması için yöntemler.
CN103110580B (zh) * 2013-02-20 2014-09-17 北京德立福瑞医药科技有限公司 丁酸氯维地平注射剂
KR101862448B1 (ko) * 2013-04-12 2018-05-29 바이옴 바이오사이언스 피브이티. 엘티디. 항균제의 조성물과 제제, 그 공정, 및 세균 감염을 치료하는 방법
US11737989B2 (en) 2014-05-19 2023-08-29 Chiesi Farmaceutici S.P.A. Clevidipine nanoparticles and pharmaceutical compositions thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4217842A1 (de) * 1992-05-29 1993-12-02 Dietl Hans Calciumantagonisten enthaltende pharmazeutische Zubereitung zur intravenösen und intrakoronaren Applikation sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
PT727997E (pt) 2002-07-31
IS4224A (is) 1995-05-13
FI961999L (fi) 1996-05-10
FI961999A0 (fi) 1996-05-10
CN1136774A (zh) 1996-11-27
CZ290772B6 (cs) 2002-10-16
WO1995013066A1 (en) 1995-05-18
EP0727997B1 (de) 2002-02-13
AU1037195A (en) 1995-05-29
HU9601268D0 (en) 1996-07-29
DE69429871T2 (de) 2002-08-22
FI116999B (fi) 2006-05-15
HU223142B1 (hu) 2004-03-29
KR100345627B1 (ko) 2003-03-15
SK59796A3 (en) 1996-12-04
NO314877B1 (no) 2003-06-10
ES2172572T3 (es) 2002-10-01
CA2176360A1 (en) 1995-05-18
DE69429871D1 (de) 2002-03-21
DK0727997T3 (da) 2002-04-22
HUT74474A (en) 1996-12-30
UA40633C2 (uk) 2001-08-15
MY121201A (en) 2006-01-28
NO961898D0 (no) 1996-05-10
SE9303744D0 (sv) 1993-11-12
IL111345A0 (en) 1994-12-29
EE03223B1 (et) 1999-10-15
IL111345A (en) 2000-08-31
JP3759951B2 (ja) 2006-03-29
PL314263A1 (en) 1996-09-02
RU2144358C1 (ru) 2000-01-20
US5739152A (en) 1998-04-14
PL181462B1 (pl) 2001-07-31
EG20764A (en) 2000-01-31
HK1013261A1 (en) 1999-08-20
CN1072934C (zh) 2001-10-17
NO961898L (no) 1996-06-25
CA2176360C (en) 2005-08-23
IS2036B (is) 2005-08-15
NZ276197A (en) 1997-04-24
EP0727997A1 (de) 1996-08-28
CZ133896A3 (en) 1996-09-11
JPH09505045A (ja) 1997-05-20
ZA948180B (en) 1995-05-12
AU678650B2 (en) 1997-06-05
SA94150314B1 (ar) 2005-06-14
SK283271B6 (sk) 2003-04-01

Similar Documents

Publication Publication Date Title
DE69429871D1 (de) Pharmazeutische emulsion
NO973730D0 (no) Faste virkestofftilberedninger
FI970858A0 (fi) Tirilasadin parenteraalinen apuliuotinformulaatio
IT1285387B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
SE9303281D0 (sv) New formulation
PT692028E (pt) Farmacos baseados em papilomavirus
NO870560L (no) Nytt farmasoeytisk preparat.
IT1285398B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
DE69525649D1 (de) Lamotrigin haltiges arzneimittel
DK0706395T3 (da) Lægemiddel med analgetisk effekt med minimal bevægelsesblokade
SE9401596D0 (sv) New compounds
SE9501773D0 (sv) New use
DK0850225T3 (da) Mellemprodukt til fremstilling af en farmaceutisk aktiv forbindelse
IT8821880A0 (it) Composto terapeuticamente utile, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification